search
Back to results

One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve

Primary Purpose

Coronary Artery Disease

Status
Completed
Phase
Not Applicable
Locations
Russian Federation
Study Type
Interventional
Intervention
FFR
Sponsored by
I.M. Sechenov First Moscow State Medical University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Coronary Artery Disease focused on measuring noninvasive assessment of the fractional flow reserve, coronary computed tomography angiography

Eligibility Criteria

18 Years - 85 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Patients providing written informed consent
  2. Scheduled to undergo clinically-indicated non-emergent invasive coronary angiography (ICA)
  3. Has undergone >640 multidetector CCTA within 60 days prior to ICA
  4. No cardiac interventional therapy between the CCTA and ICA

Exclusion Criteria:

  1. Prior coronary artery bypass graft (CABG) surgery
  2. Prior percutaneous coronary intervention (PCI) for which suspected coronary artery lesion(s) are within a stented coronary vessel
  3. Contraindication to adenosine, including 2nd or 3rd-degree heart block; sick sinus syndrome; long QT syndrome; severe hypotension, severe asthma, severe COPD or bronchodilator-dependent COPD
  4. Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina)
  5. Recent prior myocardial infarction within 40 days of ICA
  6. Known complex congenital heart disease
  7. Prior pacemaker or internal defibrillator lead implantation
  8. Prosthetic heart valve
  9. Significant arrhythmia or tachycardia
  10. Impaired chronic renal function (serum creatinine >1.5 mg/dl
  11. Patients with known anaphylactic allergy to iodinated contrast
  12. Pregnancy or unknown pregnancy status
  13. Body mass index >35
  14. Patient requires an emergent procedure
  15. Evidence of ongoing or active clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure with systolic blood pressure <90 mmHg, and severe congestive heart failure (NYHA III or IV) or acute pulmonary edema
  16. Any active, serious, life-threatening disease with a life expectancy of less than 2 months
  17. Inability to comply with study procedures

Sites / Locations

  • Daria Gognieva

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

FFRct

Arm Description

Patients will receive cCTA, ICA, FFRct, and FFRinv per protocol.

Outcomes

Primary Outcome Measures

Diagnostic Accuracy of FFRct
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of FFRct at the vessel level using binary outcomes whith compared to FFR as the reference standard.

Secondary Outcome Measures

Full Information

First Posted
December 22, 2018
Last Updated
May 14, 2020
Sponsor
I.M. Sechenov First Moscow State Medical University
search

1. Study Identification

Unique Protocol Identification Number
NCT03797118
Brief Title
One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve
Official Title
The First Experience With Using a One-dimensional Mathematical Model With Fully Automated Algorithm of Extraction of Patient-specific Geometry From CT Images for a Noninvasive Assessment of Fractional Flow Reserve.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2020
Overall Recruitment Status
Completed
Study Start Date
April 5, 2017 (Actual)
Primary Completion Date
June 5, 2019 (Actual)
Study Completion Date
July 5, 2019 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
I.M. Sechenov First Moscow State Medical University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
This study evaluates the diagnostic efficiency of an automated method of noninvasive assessment of the fractional reserve of coronary blood flow. Fractional flow reserve is estimated with a one-dimensional mathematical model constructed by means of an automated algorithm. Noninvasive method values are thereafter compared with invasive method values.
Detailed Description
Noninvasive assessment of Fractional Flow Reserve is almost never applied in the Russian Federation due to the relative novelty and study insufficiency, lack of the appropriate resource base, specific necessary software and trained qualified personnel. In 2015, scientists from the Institute of Numerical Mathematics RAS in collaboration with specialists of the I.M. Sechenov First Moscow State Medical University developed a noninvasive method of fractional flow reserve assessment based on a one-dimensional mathematical model. A model is constructed based on images derived from the coronary computed tomography angiography performed by standard protocol; the method is fully automated. The aim of our study is to evaluate the diagnostic efficiency of this technique in clinical practice. This is a pilot study; we are planning to enroll 30 patients: 13 of them underwent 64-slice computed tomography and are included retrospectively; 17 will be included prospectively, with a 640-slice CT scan. Specialists from the Laboratory of Mathematical Modeling will process CT images and evaluate noninvasive FFR. Ischemia is confirmed if FFR < 0.80 and disproved if FFR ≥ 0.80. After that, the prospective group of patients will be hospitalized for invasive FFR assessment as a reference standard; if ischemia is proved, patients will undergo stent implantation. In the retrospective group, patients already have invasive FFR values estimated. Statistical analysis will be performed using R programming language packages (cran-r.project.com). Continuous variables will be presented as mean values ± standard deviations, order variables will be presented as medians with interquartile ranges in parentheses. We are going to use the D'Agostino-Pearson omnibus test for the assessment of normality of distribution and construct a Q-Q Plot. We will compare these two methods with the Bland-Altman analysis and ROC-analysis and will assess the degree of correlation with the Pearson's chi-squared. The study should result in determining the sensitivity, specificity, positive and negative predictive values of the method. After the active phase of the research is done, we are planning to proceed observation on the prospective group of patients to verify the endpoints.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease
Keywords
noninvasive assessment of the fractional flow reserve, coronary computed tomography angiography

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
31 (Actual)

8. Arms, Groups, and Interventions

Arm Title
FFRct
Arm Type
Experimental
Arm Description
Patients will receive cCTA, ICA, FFRct, and FFRinv per protocol.
Intervention Type
Device
Intervention Name(s)
FFR
Intervention Description
Fractional flow reserve measured during cardiac catheterization
Primary Outcome Measure Information:
Title
Diagnostic Accuracy of FFRct
Description
Sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) of FFRct at the vessel level using binary outcomes whith compared to FFR as the reference standard.
Time Frame
through study completion, an average of 8 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
85 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Patients providing written informed consent Scheduled to undergo clinically-indicated non-emergent invasive coronary angiography (ICA) Has undergone >640 multidetector CCTA within 60 days prior to ICA No cardiac interventional therapy between the CCTA and ICA Exclusion Criteria: Prior coronary artery bypass graft (CABG) surgery Prior percutaneous coronary intervention (PCI) for which suspected coronary artery lesion(s) are within a stented coronary vessel Contraindication to adenosine, including 2nd or 3rd-degree heart block; sick sinus syndrome; long QT syndrome; severe hypotension, severe asthma, severe COPD or bronchodilator-dependent COPD Suspicion of acute coronary syndrome (acute myocardial infarction and unstable angina) Recent prior myocardial infarction within 40 days of ICA Known complex congenital heart disease Prior pacemaker or internal defibrillator lead implantation Prosthetic heart valve Significant arrhythmia or tachycardia Impaired chronic renal function (serum creatinine >1.5 mg/dl Patients with known anaphylactic allergy to iodinated contrast Pregnancy or unknown pregnancy status Body mass index >35 Patient requires an emergent procedure Evidence of ongoing or active clinical instability, including acute chest pain (sudden onset), cardiogenic shock, unstable blood pressure with systolic blood pressure <90 mmHg, and severe congestive heart failure (NYHA III or IV) or acute pulmonary edema Any active, serious, life-threatening disease with a life expectancy of less than 2 months Inability to comply with study procedures
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Daria Gognieva, MD
Organizational Affiliation
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Official's Role
Principal Investigator
First Name & Middle Initial & Last Name & Degree
Philipp Kopylov, Professor
Organizational Affiliation
I.M. Sechenov First Moscow State Medical University (Sechenov University)
Official's Role
Study Director
Facility Information:
Facility Name
Daria Gognieva
City
Moscow
ZIP/Postal Code
127540
Country
Russian Federation

12. IPD Sharing Statement

Plan to Share IPD
No
IPD Sharing Plan Description
Data disclosure is not permitted by the local ethics committee. For more information about the study, you need to contact the principal investigator.
Citations:
PubMed Identifier
29921835
Citation
Gognieva D, Gamilov T, Pryamonosov R, Betelin V, Ternovoy SK, Serova NS, Abugov S, Shchekochikhin D, Mitina Y, El-Manaa H, Kopylov P. One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve in a Patient with Silent Myocardial Ischemia. Am J Case Rep. 2018 Jun 20;19:724-728. doi: 10.12659/AJCR.908449.
Results Reference
background
Links:
URL
https://www.ncbi.nlm.nih.gov/pubmed?term=Am+J+Case+Rep+%5BJour%5D+AND+One-Dimensional+Mathematical+Model-Based+Automated+Assessment+of+Fractional+Flow+Reserve+in+a+Patient+with+Silent+Myocardial+Ischemia&TransSchema=title&cmd=detailssearch
Description
Am J Case Rep. 2018 Jun 20;19:724-728. doi: 10.12659/AJCR.908449.

Learn more about this trial

One-Dimensional Mathematical Model-Based Automated Assessment of Fractional Flow Reserve

We'll reach out to this number within 24 hrs